Exagen Inc (XGN) Company Profile & Statistics

Exagen Inc
XGN
(Nasdaq - US)
Closed
3.86
-0.34 (-8.10%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
4.65
High
4.65
Low
3.85

About Exagen Inc

CEO

John Aballi

Headquarters

1261 liberty way

vista, ca 92081, united states

Auditor

BDO USA, P.C.

Employees

179

Share Holders

Website

www.exagen.com

Industry

medical or nursing services

Sector

health services

Company Overview

Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California.

Exagen Inc Statistics

Valuation Measures

Market Capitalization ²	68.09M
Enterprise Value	66.31M
Enterprise Value/EBITDA (ttm)	-4.94
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.77
Price to Sales (ttm)	1.12
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	58.69%
Operating Margin (ttm)	-30.36%
Profit Margin (ttm)	-30.92%
Return on Equity (ttm)	-92.58%
Return on Invested Capital (ttm)	-45.16%
Return on Assets (ttm)	-33.74%

Income Statement

Revenue (ttm)	55.75M
Revenue Per Share (ttm)	3.16
Gross Profit (ttm)	32.78M
EBITDA (ttm)³	-13.44M
Net Income Avi to Common (ttm)	-16.93M
Diluted EPS (ttm)	-0.94

Share Statistics

Beta (5Y Monthly)	1.35
52-Week Change	147.44%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	17.64M
Dividend Yield	0.00%
Float ⁴	13.03M
% Held by Insiders	26.10%
% Held by Institutions	75.25%

Balance Sheet

Total Cash (mrq)	22.04M
Total Cash Per Share (mrq)	1.25
Total Debt (mrq)	20.25M
Total Debt/Equity (mrq)	157.39%
Current Ratio (mrq)	4.05%
Quick Ratio (mrq)	4.05%
Book Value Per Share (mrq)	0.73

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.75
Free Cash Flow (ytd)	-14.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Exagen Inc

Trade With A Regulated Broker